Mr. R.A. Shah – Chairman.
Mr. R.A. Shah is a leading Solicitor and a Senior Partner of M/s. Crawford Bayley
& Co., a firm of Advocates & Solicitors. He specializes in a broad spectrum
of corporate laws in general, with special focus on Foreign Investments, Joint Ventures,
Technology and License Agreement, Intellectual Property Rights, Mergers and Acquisitions,
Industrial Licensing, and Anti Trust Laws, Company Law and Taxation. He is the Chairman/Director
of various public limited companies and Chairman/member of Audit Committees.
Mr. R.A. Shah was first appointed on the Board on November 9, 1965.
Mr. Pradip P. Shah – Director
Mr. Pradip Shah holds an MBA from the Harvard Business School. He is also a Chartered
Accountant and a Cost Accountant and ranked first in India in the Chartered Accountancy
Mr. Pradip Shah is the ex-Managing Director of CRISIL, India’s first and the
largest credit rating agency. Prior to founding CRISIL, Mr. Pradip Shah assisted
in founding the Housing Development Finance Corporation (HDFC) in 1977. Mr. Shah
has also served as a consultant to USAID, the World Bank and the Asian Development
Bank. Mr. Shah is a Director on the Board of several reputed companies. He is also
a member of various prestigious committees/commissions. Mr. Pradip Shah is presently
the Chairman of Indasia Fund Advisors Pvt. Ltd.
Mr. Pradip P. Shah was appointed to the Board on December 7, 1999.
Mr. Uday Khanna – Director
Mr. Uday Khanna is a Chartered Accountant. Mr. Khanna is the Chairman of Bata India Limited. Mr. Khanna was the Managing Director & CEO of Lafarge India from July 2005 to July 2011 and subsequently the Non-Executive Chairman till 24th September, 2014.
Mr. Khanna joined the Lafarge Group in Paris on June 1, 2003 as Senior Vice President for Group Strategy, after a long experience of almost 30 years with Hindustan Lever Limited / Unilever in a variety of financial, commercial and general management roles both nationally and internationally.
Mr. Khanna’s last position before joining Lafarge, was Senior Vice President Finance, Unilever - Asia, based in Singapore.
Mr. Khanna has earlier been on the Board of Hindustan Lever Limited (Hindustan Unilever Limited) as Director - Exports.
Mr. Khanna has also worked as Vice Chairman of Lever Brothers in Nigeria and General Auditor for Unilever-North America based in the USA.
Mr. Khanna was the President of the Indo-French Chamber of Commerce & Industry in 2008 and 2009 and is currently President of the Bombay Chamber of Commerce & Industry and on the Managing Committee of the Associated Chamber of Commerce & Industry.
Mr. Khanna was appointed to the Board on May 21, 2012.
Mr Samir Kazi - Executive Director
Mr. Samir Kazi is a passionate lawyer with over 20 years of rich experience in the field of legal affairs. Mr. Kazi earned his Bachelor of Law degree from the University of Mumbai in the year 1999.
Mr. Kazi started his career with an illustrious law firm in Mumbai, Mulla & Mulla & Craigie Blunt & Caroe, where he practiced law for over 7 years before taking up in-house law practice. Thereafter, Mr. Kazi was a Legal advisor to the Hinduja Group India Limited, before being associated with Pfizer Limited since 2007.
Mr. Kazi is part of the Leadership team at Pfizer India and is responsible for providing quality legal advice on matters related to business operations, corporate laws, corporate & statutory compliances, litigation strategies, enforcement of intellectual property rights, mergers and acquisitions which include establishment of strategic alliances, partnerships and relationships with internal and external clients.
Apart from his professional profile, Mr. Kazi also takes a keen interest in shaping careers of law students and actively provides guidance and vocational trainings to enhance their skillset and knowledge.
Mr. Kazi was appointed to the Board on February 14, 2020.
Mr. S. Sridhar — Managing Director
Mr. S. Sridhar is leading Pfizer Inc’s commercial business in India. He has in his career successfully steered many strategic projects, global brand launches, business restructuring actions, Mergers & Acquisitions and Joint Ventures. A Chartered Accountant with three decades of experience, Sridhar has successfully donned multiple hats in his career as Chief Financial Officer, Business Unit/Supply Chain Head and the Managing Director of Pfizer India business since March 2016.
Sridhar is the President of Organisation of Pharmaceutical Producers of India (an association of Research Based Organisations) and is also the Chair of its Finance and Taxation Work Group. He is also the Former Chair of The Federation of Indian Chambers of Commerce and Industry (FICCI) Pharma Committee. In this capacity, he has effectively advocated for policies that are pro patient, encourage innovation and provide for a positive environment for the industry to grow.
Prior to joining Pfizer, Sridhar spent 13 years with Diageo, the world’s largest alcoholic beverages company. He was the Finance Director when he left Diageo India.
Mr. Sunil S. Lalbhai – Director
Mr. Sunil S. Lalbhai, holds MS degree in Chemistry from the University of Massachusetts and MS degree in Economic Policy and Planning from Northeastern University. Mr. Lalbhai has expertise and wide experience in the Management field. He is presently the Chairman and Managing Director of Atul Limited, a diversified chemical company where he has been working since 1983.
Mr. Lalbhai was also on the Board of Wyeth Limited since 2002 till its amalgamation with Pfizer Limited.
Mr. Lalbhai was appointed to the Board on February 14, 2015.
Mr. Milind Patil – Executive Director
Mr. Milind Patil is a graduate of commerce and a fellow member of the Institute of Chartered Accountants of India. Mr. Patil has also completed financial excellence program & financial leadership program and advance leadership program from Harvard Business School, USA and Tuck School of Management, USA respectively.
Mr. Milind Patil joined Pfizer Limited effective August 16, 2018 as the Chief Financial Officer. Mr. Milind Patil is a finance professional with over two decades of experience predominantly in the Pharmaceutical industry and having versatile exposure in global MNCs in challenging and complex business environments across multiple finance and business functions. He has a proven track record in business turnaround strategies and managing stakeholders, people, performance and risks and opportunities effectively. Mr. Patil’s last employment was as Chief Financial Officer for Middle East North Africa (MENA) region for Novartis based out of Dubai.
Mr. Milind Patil was awarded the “CA.CFO-healthcare sector award” by the Institute of Chartered Accountants of India in February 2015.
Mr. Milind Patil was appointed to the Board on November 14, 2018.
Ms. Meena Ganesh – Director
Ms. Meena Ganesh is a PGDM holder from IIM Calcutta and has a graduate degree in Physics from the Madras University. In 2011, she was conferred the ‘Distinguished Alumnus’ award by IIM Calcutta.
Ms. Meena Ganesh is one of India’s foremost business leaders and most successful entrepreneurs with nearly three decades of experience in industries including healthcare, consulting, technology, outsourcing, education and e-commerce. Ms. Meena Ganesh is the MD & CEO of Portea Medical, One of India’s largest and fastest growing home healthcare companies, which she co-founded in July 2013.
Ms. Meena Ganesh was appointed to the Board on March 8, 2019.
Composition of Committees of Board of Directors – Pfizer Limited